SLGL — SOL-GEL TECHNOLOGIES Share News
0.000.00%
Last trade - 00:00- $227.38m
- $179.45m
- $19.39m
Brief: Sol-Gel Announces Pricing Of Public Offering Of Ordinary Shares And Warrants To Purchase Ordinary Shares
Brief: Sol-Gel Announces Positive Topline Results From Open-Label, Long-Term Safety Study Of Epsolay® For Treatment Up To 52 Weeks
NDA Submission Of Epsolay Anticipated In First Half Of 2020
Brief: Sol-Gel Announces Presentation Of Data For Its Topical Product Candidates For Acne And Rosacea
Brief: Sol Gel Technologies Files For Offering Of Up To $25 Mln Of Ordinary Shares
Brief: Sol-Gel Announces Initiation Of SGT-210 Phase 1 Proof Of Concept Study In Palmoplantar Keratoderma
U.S. STOCKS ON THE MOVE-Avon Products, Sina Corp, Core Laboratories, Halliburton
U.S. STOCKS ON THE MOVE-Uber, Dick's Sporting, Tencent, Schlumberger
U.S. STOCKS ON THE MOVE-Tencent Music, Neovasc, FirstEnergy, McDermott International
U.S. STOCKS ON THE MOVE-McDermott International, Core Laboratories, Nio, resTORbio
Sol-Gel's acne drug could emerge as a significant topical treatment - Jefferies
U.S. STOCKS ON THE MOVE-Rite Aid, Red Robin Gourmet Burgers, Tesla, Five Star Senior Living
U.S. STOCKS ON THE MOVE-Tesla, Nio, Wave Life Sciences, Franchise Group
NASDAQ RESUMED AT 10:20 AM
NASDAQ RESUMED AT 10:11 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:05 AM
U.S. STOCKS ON THE MOVE-Wave Life Sciences, Savara Inc, Tesla, Briggs & Stratton
Sol-Gel acne cream reduces marks in late-stage studies, shares soar (updated)
Brief: Sol-Gel Announces Positive Top-Line Phase 3 Trial Results Of Twyneo